Meet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
Expert insights on API manufacturing, CDMO trends, peptide development, and pharmaceutical industry news from Neuland Labs.
Scale-Up and ManufacturingAPI stability requires continuous monitoring and phase-appropriate testing throughout a molecule's development lifecycle to ensure quality, shelf life, and regulatory compliance from early development through commercial supply.
Scale-Up and ManufacturingThis article explains the five stages of drug development, from discovery through commercial manufacturing, and how timelines, complexity, and manufacturing needs vary across different therapeutic modalities like small molecules, peptides, and biologics.
Scale-Up and ManufacturingBatch consistency in commercial API production is engineered through Quality by Design and process validation to ensure reliable, predictable manufacturing outcomes that meet specifications across all batches.
Scale-Up and ManufacturingSynthesis scouting is a systematic evaluation of alternative chemical routes to select the most efficient, scalable, safe, and cost-effective manufacturing process for active pharmaceutical ingredients.
Scale-Up and ManufacturingNeuland Laboratories explains why pharmaceutical companies choose them for complex API manufacturing, covering process development, peptide production, regulatory expertise, and technology transfer capabilities.
Scale-Up and Manufacturing
Scale-Up and Manufacturing
Scale-Up and Manufacturing
Scale-Up and Manufacturing